Neurological manifestations of long-COVID syndrome: a narrative review
MI Stefanou, L Palaiodimou, E Bakola… - … advances in chronic …, 2022 - journals.sagepub.com
Accumulating evidence points toward a very high prevalence of prolonged neurological
symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no …
symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no …
[HTML][HTML] Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb
M Khan, SJ Yoo, M Clijsters, W Backaert, A Vanstapel… - Cell, 2021 - cell.com
Anosmia, the loss of smell, is a common and often the sole symptom of COVID-19. The onset
of the sequence of pathobiological events leading to olfactory dysfunction remains obscure …
of the sequence of pathobiological events leading to olfactory dysfunction remains obscure …
[HTML][HTML] Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study
M Augustin, P Schommers, M Stecher… - The Lancet Regional …, 2021 - thelancet.com
Background While the leading symptoms during coronavirus disease 2019 (COVID-19) are
acute and the majority of patients fully recover, a significant fraction of patients now …
acute and the majority of patients fully recover, a significant fraction of patients now …
Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis
Background and objectives One year after the onset of the coronavirus disease 2019
(COVID-19) pandemic, we aimed to summarize the frequency of neurologic manifestations …
(COVID-19) pandemic, we aimed to summarize the frequency of neurologic manifestations …
[HTML][HTML] Long Covid-19: proposed primary care clinical guidelines for diagnosis and disease management
A Sisó-Almirall, P Brito-Zerón… - International journal of …, 2021 - mdpi.com
Long COVID-19 may be defined as patients who, four weeks after the diagnosis of SARS-
Cov-2 infection, continue to have signs and symptoms not explainable by other causes. The …
Cov-2 infection, continue to have signs and symptoms not explainable by other causes. The …
International consensus statement on allergy and rhinology: olfaction
Background The literature regarding clinical olfaction, olfactory loss, and olfactory
dysfunction has expanded rapidly over the past two decades, with an exponential rise in the …
dysfunction has expanded rapidly over the past two decades, with an exponential rise in the …
Clinical outcomes for patients with anosmia 1 year after COVID-19 diagnosis
M Renaud, C Thibault, F Le Normand… - JAMA network …, 2021 - jamanetwork.com
Since the pandemic was declared in early 2020, COVID-19–related anosmia quickly
emerged as a telltale sign of infection. 1, 2 However, the time course and reversibility of …
emerged as a telltale sign of infection. 1, 2 However, the time course and reversibility of …
[HTML][HTML] Síndrome post-COVID: Un documento de reflexión y opinión
E Bouza, RC Moreno, PDL Ramos… - Revista española de …, 2021 - ncbi.nlm.nih.gov
Un elevado porcentaje de las personas que han padecido COVID refieren, tras la
recuperación de la fase aguda de la enfermedad, una serie de manifestaciones clínicas …
recuperación de la fase aguda de la enfermedad, una serie de manifestaciones clínicas …
Prevalence and 24‐month recovery of olfactory dysfunction in COVID‐19 patients: a multicentre prospective study
Objective To investigate the prevalence and recovery of olfactory dysfunction (OD) in COVID‐
19 patients 24 months after the infection. Methods From 22 March 2020 to 5 June 2022, 251 …
19 patients 24 months after the infection. Methods From 22 March 2020 to 5 June 2022, 251 …